A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Orange, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Samuel Ejadi
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UC Irvine
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- PACT Pharma, Inc.
- ID
- NCT03970382
- Phase
- Phase 1
- Study Type
- Interventional
- Last Updated